Cumberland Pharmaceuticals (CPIX) Proxy Filing summary

Voting matters and shareholder proposals

• Shareholders are asked to elect three director nominees: Dr. Gordon R. Bernard, Mr. Joseph C. Galante, and Mr. A.J. Kazimi for the board.

• Proposal to ratify Carr, Riggs & Ingram, L.L.C. as the independent registered accounting firm for the fiscal year ending December 31, 2025.

• Proxies may vote on other business that may properly come before the meeting.

Board of directors and corporate governance

• Proxy authorizes A.J. Kazimi and Kenneth J. Krogulski, or either, to vote on behalf of shareholders at the annual meeting.

• Shareholders can revoke proxies by written notice, submitting a later-dated proxy, or voting in person at the meeting.

Audit committee and external auditor matters

• Ratification of Carr, Riggs & Ingram, L.L.C. as the external auditor for the 2025 fiscal year is up for shareholder approval.